tiprankstipranks
Trending News
More News >
NFL Biosciences SA (DE:82F)
:82F
Germany Market

NFL Biosciences SA (82F) Financial Statements

Compare
1 Followers

NFL Biosciences SA Financial Overview

NFL Biosciences SA's market cap is currently €14.51M. The company's EPS TTM is €-0.212; its P/E ratio is ―; NFL Biosciences SA is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 0.00€ 0.00€ 0.00
Gross Profit€ -2.24M€ -530.73K€ -169.36K
Operating Income€ -3.08M€ -901.87K€ -318.03K
EBITDA€ -2.81M€ -1.08M€ -271.09K
Net Income€ -2.44M€ -978.24K€ -266.49K
Balance Sheet
Cash & Short-Term Investments€ 1.21M€ 3.20M€ 310.20K
Total Assets€ 2.40M€ 3.69M€ 576.64K
Total Debt€ 83.26K€ 85.01K€ 85.00K
Net Debt€ -970.33K€ -2.95M€ -225.20K
Total Liabilities€ 1.55M€ 397.73K€ 426.61K
Stockholders' Equity€ 844.00K€ 3.29M€ 150.03K
Cash Flow
Free Cash Flow€ 104.89K€ 87.00K€ 83.91K
Operating Cash Flow€ 104.89K€ 87.00K€ 83.91K
Investing Cash Flow€ 0.00€ 0.00€ 0.00
Financing Cash Flow€ 0.00€ 0.00€ 0.00
Currency in EUR

NFL Biosciences SA Earnings and Revenue History

NFL Biosciences SA Debt to Assets

NFL Biosciences SA Cash Flow

NFL Biosciences SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis